Immunotherapy against tau pathology in mouse models requires cytosolic Fc receptor TRIM21
Background The passive transfer of monoclonal antibodies reduces tau pathology in mouse models and is under evaluation as a potential immunotherapeutic strategy against Alzheimer’s disease and other tauopathies. The mechanisms that drive therapeutic protection of anti‐tau antibodies are not well und...
Gespeichert in:
| Veröffentlicht in: | Alzheimer's & dementia 2023-12, Vol.19 (S13), p.n/a |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!